Phase II Trial Of Observation For Low-Risk Meningiomas And Of Radiotherapy For Intermediate and High-Risk Meningiomas
RATIONALE: Sometimes a tumor may not need treatment until it progresses. In this case,
observation may be sufficient. Specialized radiation therapy that delivers a high dose of
radiation directly to the tumor, such as 3-dimensional conformal radiation therapy and
intensity-modulated radiation therapy, may kill more tumor cells and cause less damage to
normal tissue. It is not yet known whether observation is more effective than radiation
therapy in treating patients with meningioma.
PURPOSE: This phase II trial is studying observation to see how well it works compared with
radiation therapy in treating patients with grade I, grade II, or grade III meningioma.
Keene,St. Johnsbury, VT
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.